Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2017

Pharma News, 2017

Chi-Med Initiates a Phase II Combination Study of Fruquintinib with Iressa® (gefitinib) in First-Line Non-Small Cell Lung Cancer
Chi-Med Initiates a Phase II Combination Study of Fruquintinib with Iressa® (gefitinib) in First-Line Non-Small Cell Lung Cancer
LONDON, UK I January 16, 2017 I Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq.
Uncovered: Spicy Indian pepper has powerful anti-cancer properties
Uncovered: Spicy Indian pepper has powerful anti-cancer properties
New Delhi.
Oral iron drug found safe and effective for treating anemia in kidney disease patients
Oral iron drug found safe and effective for treating anemia in kidney disease patients
Washington, DC (January 13, 2017) -- An oral iron formulation may be a safe and effective treatment for anemia in patients with chronic kidney disease, according to a new study.
Takeda in $125M Maverick T-cell research deal with a 5-year buyout clause
Takeda in $125M Maverick T-cell research deal with a 5-year buyout clause
Fresh off its $5.
Pharma giant Pfizer opens new $50m Saudi manufacturing hub
Pharma giant Pfizer opens new $50m Saudi manufacturing hub
The Saudi subsidiary of pharmaceutical giant Pfizer has announced the opening of a new $50 million manufacturing facility in the Gulf kingdom.
U.S. biotech opening plant in Ireland after issues with CMO delay glaucoma drug
U.S. biotech opening plant in Ireland after issues with CMO delay glaucoma drug
Aerie Pharmaceutical has decided to build a manufacturing plant in Ireland for future production of its eye drug.
Concussions could cause Alzheimer's: Researchers find clearest ever link between mild head injuries and the tragic brain disease
Concussions could cause Alzheimer's: Researchers find clearest ever link between mild head injuries and the tragic brain disease
Concussions drastically increase one's risk of developing Alzheimer's disease, new research shows.
EU approves Gilead’s hepatitis B therapy Vemlidy
EU approves Gilead’s hepatitis B therapy Vemlidy
Patients with chronic hepatitis B in Europe have gained the firm new treatment option in nearly 10 years following the approval of  Gilead's Vemlidy.
AbbVie vows to keep drug price increases below 10 percent
AbbVie vows to keep drug price increases below 10 percent
AbbVie Inc Chief Executive Richard Gonzalez on Wednesday promised to keep all drug price increases in 2017 under 10 percent, becoming the third global drugmaker to publicly make that pledge.
More Than 100 Biopharma Execs Are Pushing for More Gender Diversity in the Industry
More Than 100 Biopharma Execs Are Pushing for More Gender Diversity in the Industry
At least 100 biopharma executives from major drug makers like Eli Lilly (lly), Johnson & Johnson (jnj), Bayer, Novartis (nvs), and a slew of biotech CEOs have signed an ope...
Could a chicory compound reduce Alzheimer's-related memory loss?
Could a chicory compound reduce Alzheimer's-related memory loss?
Memory loss is a key characteristic of Alzheimer's disease, which is a condition that affects more than 5.
MIT's 3D graphene is ten times stronger than steel
MIT's 3D graphene is ten times stronger than steel
An awful lot of ink has been spilled about how graphene is going to basically save the world with its myriad applications and powers.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand